1. Home
  2. AKBA vs WTBA Comparison

AKBA vs WTBA Comparison

Compare AKBA & WTBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.38

Market Cap

380.4M

Sector

Health Care

ML Signal

HOLD

Logo West Bancorporation

WTBA

West Bancorporation

HOLD

Current Price

$23.64

Market Cap

375.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
WTBA
Founded
2007
1893
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
380.4M
375.9M
IPO Year
2014
2002

Fundamental Metrics

Financial Performance
Metric
AKBA
WTBA
Price
$1.38
$23.64
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$5.75
$24.00
AVG Volume (30 Days)
2.5M
26.9K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
4.24%
EPS Growth
93.94
35.21
EPS
N/A
1.92
Revenue
N/A
N/A
Revenue This Year
N/A
$23.69
Revenue Next Year
N/A
$9.18
P/E Ratio
N/A
$12.27
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$17.33
52 Week High
$4.08
$26.60

Technical Indicators

Market Signals
Indicator
AKBA
WTBA
Relative Strength Index (RSI) 51.06 48.33
Support Level $1.30 $23.57
Resistance Level $1.55 $24.16
Average True Range (ATR) 0.07 0.75
MACD 0.00 0.00
Stochastic Oscillator 50.70 70.52

Price Performance

Historical Comparison
AKBA
WTBA

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About WTBA West Bancorporation

West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.

Share on Social Networks: